163 related articles for article (PubMed ID: 29497873)
1. Safety of long-term anticoagulation in patients with brain metastases.
Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
[TBL] [Abstract][Full Text] [Related]
2. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
[TBL] [Abstract][Full Text] [Related]
4. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
[TBL] [Abstract][Full Text] [Related]
5. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
[TBL] [Abstract][Full Text] [Related]
6. Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases.
Leader A; Hamulyák EN; Carney BJ; Avrahami M; Knip JJ; Rozenblatt S; Beenen LFM; Yust-Katz S; Icht O; Coppens M; Raanani P; Middeldorp S; Büller HR; Zwicker JI; Spectre G
Blood Adv; 2020 Dec; 4(24):6291-6297. PubMed ID: 33351124
[TBL] [Abstract][Full Text] [Related]
7. Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.
Srivastava G; Rana V; Wallace S; Taylor S; Debnam M; Feng L; Suki D; Karp D; Stewart D; Oh Y
J Thorac Oncol; 2009 Mar; 4(3):333-7. PubMed ID: 19190519
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases.
Abdelmessih E; Ahuja T; Wo S; Sango A; Papadopoulos J; Green D; Xiang E
J Thromb Thrombolysis; 2024 Mar; 57(3):418-427. PubMed ID: 38281232
[TBL] [Abstract][Full Text] [Related]
9. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Rojas-Hernandez CM; Oo TH; García-Perdomo HA
J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
[TBL] [Abstract][Full Text] [Related]
10. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
Zwicker JI; Karp Leaf R; Carrier M
J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
[TBL] [Abstract][Full Text] [Related]
12. Intracranial hemorrhage in cancer patients treated with anticoagulation.
Weinstock MJ; Uhlmann EJ; Zwicker JI
Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980
[TBL] [Abstract][Full Text] [Related]
13. Balancing bleeding in brain metastases.
Kreuziger LB
Blood; 2015 Jul; 126(4):432-3. PubMed ID: 26206944
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
Mantia C; Zwicker JI
Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
[TBL] [Abstract][Full Text] [Related]
15. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation.
Lee V; Jairam V; Yu JB; Park HS
Sci Rep; 2020 Jun; 10(1):10084. PubMed ID: 32572113
[TBL] [Abstract][Full Text] [Related]
16. [Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy].
Varvat J; Epinat M; Nuti C; Antoine JC; Mismetti P; Garnier P
Therapie; 2013; 68(3):143-7. PubMed ID: 23886458
[TBL] [Abstract][Full Text] [Related]
17. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
[TBL] [Abstract][Full Text] [Related]
18. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
[TBL] [Abstract][Full Text] [Related]
19. Intracranial hemorrhage and oral anticoagulant treatment.
Neau JP; Couderq C; Ingrand P; Blanchon P; Gil R;
Cerebrovasc Dis; 2001; 11(3):195-200. PubMed ID: 11306767
[TBL] [Abstract][Full Text] [Related]
20. Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.
Witt DM; Delate T; Hylek EM; Clark NP; Crowther MA; Dentali F; Ageno W; Martinez KD; Garcia DA
Thromb Res; 2013; 132(6):770-5. PubMed ID: 24521790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
